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Abstract
Immune dysregulation has been noted consistently in individuals with autism spectrum disorder 
(ASD) and their families, including the presence of autoantibodies reactive to fetal brain proteins 
in nearly a quarter of mothers of children with ASD versus less than 1% in mothers of typically 
developing children. Our lab recently identified the peptide epitope sequences on seven antigenic 
proteins targeted by these maternal autoantibodies. Through immunization with these peptide 
epitopes, we have successfully created an endogenous, antigen-driven mouse model that ensures a 
constant exposure to the salient autoantibodies throughout gestation in C57BL/6J mice. This 
exposure more naturally mimics what is observed in mothers of children with ASD. Male and 
female offspring were tested using a comprehensive sequence of behavioral assays as well as 
measures of health and development highly relevant to ASD. We found that MAR-ASD male and 
female offspring had significant alterations in development and social interactions during dyadic 
play. Although 3-chambered social approach was not significantly different, fewer social 
interactions with an estrous female were noted in the adult male MAR-ASD animals, as well as 
reduced vocalizations emitted in response to social cues with robust repetitive self-grooming 
behaviors relative to saline treated controls. The generation of MAR ASD-specific epitope 
autoantibodies in female mice prior to breeding created a model that demonstrates for the first 
time that ASD-specific antigen-induced maternal autoantibodies produced alterations in a 
constellation of ASD-relevant behaviors.
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INTRODUCTION
Autism spectrum disorders (ASD) are a set of neurodevelopmental disorders characterized 
by impaired verbal and non-verbal social communication accompanied by the presence of 
repetitive and stereotypical behaviors1. Current prevalence estimates suggest that ASD 
affects 1 in 68 children in the United States, with the average age of definitive diagnosis at 4 
years of age2. While the etiology of this highly heterogeneous disorder remains unknown, 
mounting evidence suggests that both genetic and environmental risk factors contribute to 
the development of ASD3–5. One such risk factor is immune system dysregulation, which 
has been consistently noted in individuals with ASD as well as their family members6. Most 
notably, a sub-set of mothers of children with ASD has been reported to harbor 
autoantibodies reactive to fetal brain proteins by several investigators7–10.
The maternal immune system is uniquely regulated during pregnancy under normal 
conditions, ensuring that a pathogen-free, non-inflammatory, environment is maintained for 
the developing fetus11. Maternal immunoglobulin G (IgG) antibodies are among the limited 
components of the maternal immune system that enter the fetal compartment during 
gestation, transferring at high concentrations via a specific receptor across the placenta 
beginning around mid-gestation in humans, thereby providing the immunologically naïve 
fetus with passive protection against pathogens12. In addition to immunoprotective IgG 
specific to external pathogens, maternal IgG autoantibodies that react to fetal ‘self’-proteins’ 
will also cross the placenta. Furthermore, while antibody access to the brain is normally 
inhibited by a mature blood-brain barrier (BBB), the BBB is permissive during early 
neurodevelopment and thus allows maternal IgG into the fetal brain13. Therefore, prenatal 
exposure to maternal autoantibodies reactive against fetal brain proteins has been suggested 
as a mechanism for altering the trajectory of neurodevelopment6, 14, 15.
Our laboratory initially described the presence of a two specific patterns of maternal 
autoantibody reactivity to fetal proteins at approximately 37 and 73 kDa, and 39 and 73 kDa, 
that were uniquely found among mothers of children with ASD7, 16. Maternal reactivity to 
both patterns was also observed in prospectively collected mid-gestational blood samples of 
mothers who subsequently gave birth to children with ASD17, supporting their predictive 
potential.
To provide support for the pathological significance of these brain-reactive maternal 
autoantibodies and the mechanisms by which they may exert their effects, various animal 
studies have been conducted in mice18–24 and non-human primates25, 26. One technique 
often used to generate animal models of autoimmunity is passive antibody transfer, in which 
circulating autoantibodies from an affected individual are collected and subsequently 
transferred to a healthy animal, allowing researchers to determine whether the 
autoantibodies of interest directly exert pathogenic effects in the exposed animals14. Each of 
the previously conducted animal studies have provided evidence that introduction of human 
autoantibodies reactive for proteins in the fetal brain into a pregnant female during mid-
gestation led to alterations in neurodevelopment and behaviors in offspring. For instance, 
mouse passive transfer studies have demonstrated that mice prenatally exposed to IgG from 
mothers of children with ASD had alterations in social and anxiety-like behaviors18 as well 
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as impaired motor and sensory abilities20. In a 2014 study, mice receiving a single 
intraventricular injection on embryonic day 14 of human IgG from maternal plasma with the 
37 and 73 kDa autoantibodies resulted in atypical behaviors, including stereotypical self-
grooming and increased repetitive behaviors, relative to mice similarly injected with 
maternal IgG from mothers of neurotypical controls23. Two subsequent investigations using 
the same technique showed neuroanatomical changes in the offspring, including increased 
radial glial cell proliferation along with accelerated migration, reduced numbers of cortical 
dendritic spines, as well as increased brain and neuron size21, 22. A related study utilizing a 
passive transfer approach in rhesus macaques demonstrated higher levels of motor activity 
and stereotypies among in offspring of macaque dams prenatally exposed to autoantibody-
positive ASD IgG, supporting potentially pathogenic IgG present in maternal circulation25. 
This study was followed by a more targeted approach that was designed to increase the 
duration of gestational exposure to purified IgG from mothers who tested positive for 
autoantibodies that recognized the 37/73 kDa proteins26. Macaques prenatally exposed to 
the 37/73 kDa maternal IgG exhibited aberrant behaviors that included rebuffed and 
unreciprocated social approaches and inappropriate vocalizations26. These animals also had 
increased total cerebral volume relative to control treated subjects26, further supporting 
previous work in mice showing that these specific maternal autoantibodies appear to alter 
brain growth trajectory20. These findings are of great interest, as the relationship between 
the presence of maternal autoantibodies with increased total cerebral volume has also been 
observed in humans27.
As the results from both observational and animal studies strongly suggest a role of maternal 
autoantibodies in the etiology of a subset of children with ASD, the identification of the 
targeted protein antigens for maternal autoantibody related (MAR) ASD was a critical step 
in advancing this area of ASD research. We recently determined the identity of the 
autoantigens recognized by these maternal autoantibodies in fetal brain tissue28. Through 
tandem mass spectrometry peptide sequencing, the target proteins corresponding to the 37-, 
39-, and 73-kDa bands were identified as: lactate dehydrogenase A and B (LDH-A, LDH-
B), stress-induced phosphoprotein 1 (STIP1), collapsin response mediator proteins 1 and 2 
(CRMP1, CRMP2), and Y-box binding protein 1 (YBX1)28. We also discovered an 
additional autoantigen with a molecular weight of 44-kDA corresponding to guanine 
deaminase (GDA) that was not observed during the initial screen, as it was masked by the 
presence of the heavy chain band of IgG in the fetal brain protein preparation. All of the 
identified target proteins are expressed at significant levels in the human fetal brain and have 
established roles in neurodevelopment, such as STIP1’s role in neuritogenesis29. Maternal 
autoantibody reactivity by western blot to any of the identified antigens, individually or in 
combination, was found to be significantly associated with an outcome of ASD in the child. 
Moreover, several combinations of autoantibody reactivity were identified as highly specific 
to mothers of children with ASD as they were not found in mothers of typically developing 
(TD) children. The most common pattern of combined reactivity observed exclusively in 
mothers of children with ASD moms was to LDH-A, LDH-B, STIP1, and CRMP1 (5% 
ASD mothers vs. 0% TD mothers), which coincidentally correspond to the previously 
described 37/73 kDa proteins recognized by these ASD-specific maternal autoantibodies28. 
When all antigen reactivity patterns were combined, a total of 23% of mothers of children 
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with ASD had one of the autoantibody patterns containing two or more of the target proteins 
relative to only 1% of control mothers28.
While previous passive transfer animal studies provided support for the role of brain-reactive 
maternal autoantibodies as a risk factor for ASD, they do not reflect a constant exposure to 
the salient autoantibodies throughout gestation, as would be the case clinically. In contrast, 
the development of an antigen-driven animal model would provide a targeted and constant 
exposure to the relevant autoantibodies throughout gestation. We recently utilized 
overlapping peptide microarrays to identify the immunodominant epitope sequences 
recognized by MAR ASD related maternal autoantibodies for each of the seven 
autoantigens30. These MAR ASD epitopes are highly conserved between mice and 
humans31, with an average sequence homology of 95.7% (LDH-A: 93.3 – 95.0%; LDH-B: 
77.8 – 100.0%; STIP1: 93.3 – 94.7%; CRMP1: 86.7 – 100.0%). Thus, autoantibodies that 
specifically react to the human autoantibody-specific epitopes can be generated 
endogenously in female mice in an antigen-driven mouse model. Furthermore, the use of 
peptide epitopes recognized by the human maternal autoantibodies is essential in preserving 
the specificity of MAR ASD in an endogenous animal model, as immunization with the full-
length sequences of the targeted proteins could generate autoantibodies reactive against 
multiple epitopes throughout the protein sequence that might not be relevant to MAR ASD. 
The antigen-driven approach also allows direct investigation of the cellular mechanisms 
related to changes in neurodevelopmental trajectory and subsequent behaviors, significantly 
advancing our understanding of the potential pathogenic effects exerted by the salient 
maternal autoantibodies. Therefore, the present study aimed to establish the first 
endogenous, antigen-driven animal model of MAR ASD in order to directly assess the 
pathologic significance of prenatal exposure to epitope-specific maternal autoantibodies in 
generating ASD-relevant behaviors in offspring. Considering that specific patterns of antigen 
reactivity were previously associated with distinct behavioral phenotypes within MAR 
ASD28, the establishment of an antigen-driven model specific to one of these maternal 
reactivity patterns would greatly increase its translational potential as a preclinical testing 
platform. To create our initial antigen-driven mouse model of MAR ASD, we first focused 
on the combined reactivity to LDH-A, LDH-B, STIP1, and CRMP1, which was previously 
found to be the most selective and abundant pattern associated with MAR risk for ASD28.
METHODS
Animals
Twenty-three sexually naïve C57BL/6J female mice were obtained from The Jackson 
Laboratory at four weeks of age and served as experimental dams. After weaning on 
postnatal day (PD) 21, experimental offspring were socially housed in groups of three to 
four with same-sex mice. All animals were housed in ventilated Techniplast cages in a 
temperature (68–72°F)- and humidity (~25%)- controlled colony room, on a 12:12 light:dark 
cycle with lights on at 07:00 h, and with food and water available ad libitum. In addition to 
standard bedding, a Nestlet square and shredded brown paper were provided in each cage. 
Animals were paw tattooed and/or ear punched for identification. All procedures were 
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conducted in accordance with protocols approved by the University of California, Davis 
Institutional Animal Care and Use Committee.
Synthesis of Multiple Antigenic Peptides (MAPs)
In order to generate the epitope-specific autoantibodies in female mice before breeding, 21 
custom peptides were first synthesized and purified (>95% pure) by LifeTein (LifeTein 
LLC; Sumerset, New Jersey, USA). In particular, these peptide sequences correspond to the 
recently identified peptide sequences of the immunodominant B-cell epitopes of LDH-A, 
LDH-B, STIP1 and CRMP1 (Supplemental Table 1), which reflects the originally observed 
37/73 kDa maternal banding pattern30. Peptides were synthesized as Multiple Antigenic 
Peptides (MAPs), in which four copies of the same peptide epitope are synthesized on a 
lysine-based core (MAPs-4 system). The MAPs-4 system does not require a carrier protein, 
as the dense packing of multiple copies of an epitope in combination with a high molar ratio 
produces a strong immunological response. Peptides were provided by LifeTein LLC as 
lyophilized powder; upon their arrival, lyophilized peptides were reconstituted into 
concentrated aliquots by dissolving in PBS alone, or in the event of hydrophobic peptides, 
PBS in combination with a small amount of DMSO. Concentrated aliquots were stored at 
−80°C until their use.
Treatment
Upon their arrival, sexually naïve females were randomly assigned to treatment group 
(MAR-ASD N=12; Control N = 11) and allowed to acclimate to the colony room for one 
week. All animals received a total of 5 subcutaneous immunizations, with an interval of 6 ±1 
days between each immunization. MAR-ASD treated females received injections containing 
a mixture of the 21 custom MAPs-4 peptides in addition to Freund’s complete (CFA; 
immunization 1) or Freund’s incomplete (IFA; remaining immunization) adjuvant (Sigma-
Aldrich, Saint Louis, MO) (outlined in Supplemental Table 2). Control females were treated 
similarly to the test dams substituting saline for the peptides (CFA/IFA/Saline). The 
presence of an adjuvant allows the generation of an immune response to the self-peptides.
Verification of Autoantibody Production
In order to verify the production of epitope-specific autoantibodies in treated females, 
maternal blood samples were first collected via saphenous vein prior to treatment (baseline) 
and at 4 and 9 weeks post-initial immunization. Samples were allowed to sit at room 
temperature for at least 1 hr, after which they were centrifuged at 10,000×g for 15 min, 
serum collected and stored at −80°C until use. Maternal samples were tested for reactivity to 
each of the 21 epitope-specific peptides administered during treatment via indirect capture 
enzyme-linked immunosorbant assays (ELISAs). First, NeutrAvidin coated high capacity 
plates (Pierce NeutrAvidin Coated High Capacity Clear 96-Well Plates; Thermo Scientific, 
Waltham, MA) were washed three times with PBST (Phosphate buffered saline with Tween 
20). Biotinylated peptides (PEPperPRINT; Heidelberg, Germany) corresponding to the 21 
MAPs treatment peptide sequences were then individually coated on the NeutrAvidin plates 
at 2 μg/mL in sample diluent and incubated overnight at 4°C. After incubation, non-bound 
peptides were removed, and the plate washed five times with PBST. Maternal serum samples 
(10 μg/mL) to be tested were then added to the plate and incubated for 45 min at room 
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temperature. Plates were washed five times, and then incubated for another 45 min in the 
presence of goat anti-mouse secondary antibody (InVitrogen, San Diego, CA). Following a 
series of four PBST and two PBS washes, plates were visualized at 450 nm following the 
addition of TMB substrate (3,3’, 5,5’ – tetramethylbenzidine; BD OptEIA, San Jose, CA). 
Reactivity to the intact protein antigens was additionally determined via ELISA (methods 
and results can be found in Supplemental Methods and Supplemental Table 6).
Breeding
Following confirmation of autoantibody production, MAR-ASD and control females were 
bred as harem trios with established C57BL/6J breeder males to generate experimental 
offspring. A total of at least 16 offspring (8 male, 8 female) are required to achieve optimal 
statistical power (80%) for each task, a total of at least 5 dams per treatment group are 
required. One advantage of our study design (which differs significantly from a maternal 
immune activation model) is that we can create the antibodies in the dam well before 
breeding to avoid unwanted side effects of immunization and handling stress. Thus, no 
immunizations were administered within 2 weeks, during, or after the time of breeding, 
gestation, or post-parturition. Breeding occurred in two separate cohorts (Cohorts 1 and 2), 
with male and female offspring from each litter randomly assigned to one of the following 
three behavioral testing groups: developmental milestones (Testing Group A), pup isolation-
induced ultrasonic vocalizations (Testing Group B), and juvenile and adult behaviors 
(Testing Group C) (Figure 1).
Behavioral Assays
Behavioral assessment of experimental offspring was conducted in dedicated testing rooms 
during the light phase of the circadian cycle (07:00–19:00). Mice were tested in the 
sequence indicated in Supplemental Table 3. The order of testing was determined by the 
longitudinal juvenile and adult ages required for some tests, and by the principle of 
conducting the most stressful tests last. For all behavioral assays, procedures were employed 
that are consistent with best practices from the behavioral neuroscience literature, and from 
our previous publications32–50. Behavioral testing arenas were cleaned with 70% ethanol 
before the beginning of the first test session and after each test subject. For all non-
automated assays, coded videos were scored by investigators blind to treatment status.
Developmental milestones (PD 4–14)—Pups from Cohort A (MAR-ASD: males N=8, 
females N = 14; Control: males N = 9, females N = 8) were tested for assays of 
developmental milestones and neurological reflexes every other day from postnatal days 
(PDs) 4–14, as previously described20, 32, 37, 41, 42. Parameters of physical developmental 
milestones included: body weight, body temperature, body and tail lengths, biparietal 
diameter (head width measured at top base of the pinna with a micrometer), fur 
development, pinnae detachment, eye opening, and incisor eruption. Parameters of 
behavioral developmental milestones included: righting reflex, negative geotaxis, cliff 
avoidance, forepaw grasping reflex, Preyer auditory startle reflex, level screen, vertical 
screen climbing, and bar holding.
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Pup ultrasonic vocalizations during social isolation—Separation-induced 
ultrasonic vocalizations (USVs) emitted by Cohort B pups (MAR-ASD: males N=12, 
females N = 19; Control: males N = 13, females N = 10) were measured on PD 4, 6, 8, 10, 
and 12, as described previously38, 41, 42. Pups were individually removed from their dam and 
littermates at random and gently placed in isolation container containing clean bedding 
material. The isolation container was then placed in a sound-attenuating chamber and USVs 
were recorded for 3 min by an ultrasonic microphone (Avisoft UltraSoundGate condenser 
microphone capsule CM16; Avisoft Bioacoustics, Berlin, Germany). Ultrasonic calls were 
recorded using Avisoft Recorder software, and the sampling rate was 250 kHz, format 16 
bit. At the end of the recording session, pups were returned to the nest. USV spectrograms 
were displayed using Avisoft SASLab Pro software. Calls were quantified manually from 
coded audio files by a highly-trained investigator blind to treatment status.
Juvenile reciprocal social interactions—Behavioral testing of Cohort C (MAR-ASD: 
males N=12, females N = 12; Control: males N = 11, females N = 11) began on PD 25 with 
the testing of juvenile reciprocal social interactions (JRSIs). The test was conducted in a 
Noldus PhenoTyper Observer 3000 chamber (25 × 25 × 35 cm3; Noldus Information 
Technology Inc., Leesburg, VA). The floor of the arena was covered with a layer of 
approximately 0.5 cm of clean bedding. Each experimental and stimulus partner was 
individually housed in a clean cage for 1 hr before the test. Following this isolation period, 
an individual MAR-ASD or control experimental mouse was then placed in the testing arena 
with an age- and sex-matched juvenile C57BL/6J stimulus partner mouse. Interactions were 
recorded for 10 minutes under while light (~40 Lux) conditions. Frequency of social 
behaviors was subsequently scored from coded videos by an investigator blinded to 
treatment status, using Noldus Observer software (Noldus Information Technology, 
Leesburg, VA). Parameters of juvenile mouse social behaviors were chosen from the 
established literature and from our previous studies34, 36, 40.
Elevated plus-maze—Adult offspring were tested for anxiety-like behaviors in the 
elevated plus-maze (EPM) test as previously described39, 48. Mice were individually placed 
in the center area of a black Plexiglas automated elevated plus-maze (Med-Associates, St. 
Albans City, Vermont, USA) and were allowed to freely explore the maze for 5 min. Room 
illumination was approximately 300 lux.
Light↔dark exploration—Subjects were tested in the light↔dark exploration task as a 
corroboratory measure of anxiety-like behavior, conducted in an automated chamber as 
previously described38, 42. The test began by placing the mouse in the light compartment 
facing away from the partition. The animal was allowed to freely explore the apparatus for 
10 min. Time spent in each compartment and the number of transitions between the light 
(~400 lux) and dark (~3 lux) compartments were automatically recorded.
Open field activity—General exploratory locomotion in response to a novel open field 
environment was assayed as previously described39, 45. Mice were individually placed in a 
VersaMax Animal Activity Monitoring System (AccuScan Instruments, Columbus, Ohio, 
USA) for a 30 min test session under dim lighting conditions (~30 lux).
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Three-chamber social approach—Social approach was evaluated in an automated 
three-chamber apparatus as previously described43, 44, using Noldus EthoVision XT 
videotracking software to increase throughput (version 9.0, Noldus Information 
Technologies, Leesburg, VA). The testing apparatus was a rectangular, three-chambered box 
constructed from matte white acrylic and measuring 40 × 60 × 23 cm3. Opaque retractable 
doorways (12 × 33 cm2) were designed to create optimal entryways between chamber (5 × 
10 cm2), while providing maximal division of compartments. Three zones, defined using the 
EthoVision XT software, detected time in each chamber for each phase of the assay. Zones 
to score sniffing were defined as the annulus extending 2 cm from each novel object or novel 
mouse enclosure (inverted wire cup, Galaxy Cup, Kitchen Plus, http://www.kitchen-
plus.com); direction of the head, body and tail defined sniffing the novel object or novel 
mouse. A top-mounted infrared sensitive camera (Ikegami ICD-49, B&H Photo, New York, 
NY) was positioned directly above every two units. Infrared lighting 
(Nightvisionexperts.com) provided uniform, low-level illumination. The subject mouse was 
first enclosed in the center chamber for 5 minutes, then allowed to explore all three empty 
chambers for 10 minutes, then explored the three chambers containing a novel object in one 
side chamber and a novel mouse in the other side chamber. Novel stimulus mice were 
129Sv/lmJ, a relatively inactive strain, aged 10–14 weeks old, and were matched the subject 
mice by sex. Stimulus mice were habituated as previously described50. Number of entries 
into the side chambers served as a within-task control for levels of general exploratory 
locomotion.
Male-female social interactions with USV—The male-female social interaction test 
was conducted as previously described32, 47, 49. Adult MAR-ASD and control males were 
group housed and sexually naïve at time of testing. Each freely moving experimental male 
mouse was paired with a freely moving, unfamiliar age-matched C57BL/6J female in pro-
estrus or estrus. Visual observations of vaginal swelling and color were used to determine 
estrous state, using only those females in pro-estrus or estrus (vaginal swelling and color, 
open vagina with pink or reddish pink surrounding tissue) as partner mice. A 5-minute 
testing session was conducted in a sound-attenuating chamber under red light illumination 
(~10 lux). An USV microphone (Avisoft Bioacoustics, Berlin, Germany) was additionally 
mounted 20 cm above the testing arena and contained within the chamber; sampling 
frequency for the microphone was 250 kHz, and the resolution was 16 b. Bout frequency and 
duration of social behaviors were later scored from videos using Noldus Observer software 
(Noldus Observer 8.0XT; Noldus, Leeshurg, VA). USV spectrograms were displayed using 
Avisoft software. Numbers of vocalizations were quantified manually from coded audio 
files, by a trained investigator blind to treatment group.
Neurological and physical health screen—Measures of general health and 
neurological reflexes were measured in adult male and female mice as previously 
described32. General health was assessed by fur condition, whisker condition, body and limb 
tone, and body weight; muscle strength in mice was measured with a wire hang test. 
Neurological reflexes were assessed by righting reflex, whisker twitch, pinnae response, 
eyeblink response, and forepaw reaching. Behavioral reactivity was evaluated as intensity of 
dowel biting, and level of audible distress calls when handled.
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Repetitive self-grooming—Spontaneous repetitive self-grooming behavior was scored as 
previously described32, 34, 48. Mice were individually placed in a clean, empty standard 
mouse cage without bedding (46 × 23.5 × 20 x cm3). The room was illuminated at ~30 lux, 
and a front-mounted CCTV camera (Security Cameras Direct) was placed at approximately 
1 meter from the cages to record the 20-minute testing sessions. Each mouse was first given 
a 10-minute (unscored) habituation period in the empty cage, then was scored for cumulative 
time spent grooming all body regions during the second 10 minutes of the test session. 
Scoring was performed from coded videos by a trained investigator, blind to treatment 
group.
Marble burying—Subjects were evaluated for repetitive digging behaviors using the 
marble burying task as previously described45, 48. Mice were individually placed in a 
standard mouse cage filled with 2 cm of bedding, in which 20 black glass marbles were 
arranged in a 4×5 grid on top of the bedding, under low light conditions (~30 lux). At the 
end of 30 minutes, the number of marbles buried (>50% covered by bedding) was counted 
as a measure of repetitive behavior.
Morris water maze acquisition and reversal—Spatial learning and reversal learning 
were assessed in the Morris water maze using procedures and equipment as previously 
described32, 37. The apparatus was a circular pool (120 cm diameter) filled 45 cm deep with 
tap water rendered opaque with the addition of non-toxic white paint (Crayola, Easton, PA). 
Distal room cues were black and white cardboard patterns on the walls, approximately 1 m 
from the circumference of the pool. Trials were videotaped and scored using EthoVision XT 
videotracking software (Noldus Information Technologies, Leesburg, VA). Acquisition 
training consisted of 4 trials a day for 5 days. Each training trial began by lowering the 
mouse into the water close to the pool edge, in a quadrant that was either right of, left of, or 
opposite to the target quadrant containing the platform. The start location for each trial was 
alternated in a semi-random order for each mouse. The hidden platform remained the same 
quadrant for all trials during acquisition training for a given mouse but varied across subject 
mice. Mice were allowed a maximum of 60 s to reach the platform; mice that failed to reach 
the platform in 60 s were subsequently guided to the platform by the experimenter using a 
wire cage lid. Mice were left on the platform for 15 s before being removed. After each trial, 
the subject was placed in a cage lined with absorbent paper towels and allowed to rest under 
an infrared heating lamp for 60 s. Acquisition training continued until the control group 
reached the criterion of 15 s latency to find the hidden platform. Three hours after the 
completion of acquisition training (day 5), the platform was removed, and mice were tested 
in a 60 s probe trial in order to confirm that their spatial training was acquired by using distal 
environmental room cues. Parameters recorded during training days were latency to reach 
the platform, total distance traveled, and swim speed. Time spent in each quadrant and 
number of crossings over the trained platform location and over analogous locations was 
used to analyze probe trial performance. Reversal training began 3 days after the completion 
of acquisition training. In reversal training trials, the hidden platform was moved to the 
quadrant opposite to its location during acquisition training. Procedures for reversal training 
and probe trial were the same as in the initial acquisition phase.
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Statistical Analyses
Statistical analyses were performed using SPSS software (SPSS Version 23; IBM Corp., 
Armonk, NY); p-values < 0.05 for two-tailed tests were considered statistically significant. 
Data graphs were created using GraphPad Prism (Version 6; GraphPad Software Inc., La 
Jolla, CA); all results are presented as mean ± SEM, using statistical tests previously 
described32, 36, 48. All data were first assessed for the detection of outliers by inspection of 
boxplots, with outliers defined as greater than 3 box-lengths from the edge of the box in a 
boxplot; unless otherwise noted, no outliers were detected. Analysis of variance (ANOVA) 
was used to analyze juvenile reciprocal social interactions, elevated-plus maze, light↔dark 
exploration, repetitive self-grooming, and marble bury behaviors, as well as adult 
neurological and physical health measures and developmental milestones that occurred only 
on PD 14 (between-subject factors: treatment and offspring sex). The ANOVAs with 
repeated measurements (between-subject factors: treatment and offspring sex; within-subject 
factor: time) were used to estimate the effect of time, sex, and treatment on open field 
activity, Morris water maze learning, call rate for pup isolation calls, and for most of the 
developmental milestones. Sidak post hoc analysis was conducted to compare individual 
groups in cases of a significant ANOVA value. Student’s unpaired t tests were used to 
compare across treatments on breeding parameters, on parameters of male-female reciprocal 
social interactions (MFSI), and to compare time spent sniffing novel and familiar objects in 
the 3-chambered social approach task.
RESULTS
Verification of MAR ASD-specific autoantibodies
In sexually naïve females immunized with the MAR ASD peptides, autoantibodies reactive 
against all of the targeted peptide epitope sequences were successfully produced in MAR-
ASD treated females prior to breeding (Figures 2A-D) (Supplemental Table 4). 
Furthermore, these endogenously produced maternal autoantibodies persisted to circulate at 
detectable-levels in dams post-parturition and during near the end of lactation (Figures 2E-
H) (Supplemental Table 5). Maternal reactivity to the intact proteins can be viewed in 
Supplemental Table 6.
Breeding parameters
While there were no differences in the absolute number of male pups born per litter between 
treatment groups (t(21) = 0.918, p = 0.369), MAR-ASD litters were found to produce 
significantly more female offspring than observed in control litters (t(21) = −2.204, p = 
0.039). This was additionally confirmed in comparing the percentage of average female pups 
per litter (t(21) = −2.058, p = 0.052), with a non-significant trend for MAR-ASD litters to 
produce more females than produced in control litters (MAR-ASD mean ± SE = 58.93% 
± 5.18%; control mean ± SE = 43.66% ± 5.31%). There was no significant difference 
between MAR-ASD and control litters in measuring average litter size (t(21) = −1.249, p = 
0.225).
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Developmental milestones and neurological reflexes
Markers of early physical development and neurological reflexes were assessed in neonatal 
offspring, revealing differences between MAR-ASD and control offspring in a variety of 
parameters measured. A significant main effect of treatment was observed in assessing body 
weight (F1,35 = 7.627, p = 0.009), with MAR-ASD offspring weighing significantly more 
than control offspring at all time points (p < 0.05) (Figure 3A). Furthermore, significant 
treatment × time interactions were observed for several of the physical and behavioral 
parameters measured. Most notably, the biparietal width (head width) of MAR-ASD 
offspring was found to be significantly larger relative to control offspring on PDs 10 and 12 
(treatment × time interaction: F5,175 = 5.853, p < 0.001; Sidak-adjusted post-hoc tests: PD 
10, p = 0.037; PD 12, p = 0.003) (Figure 3B). Additional measures of physical development 
with significant treatment × time interactions include pinnae detachment (F5,175 = 8.958, p < 
0.001; MAR-ASD > Control on PD 8 and 12) and fur development (F5,175 = 6.753, p < 
0.001; MAR-ASD < Control on PD 12)(Supplemental Tables 7 and 8), although these 
differences were less pronounced than the observed disparity in pup head width (biparietal 
diameter). Measures of behavioral development with significant time-dependent treatment 
effects included righting reflex (F5,175 = 3.197, p = 0.009; MAR-ASD offspring faster than 
controls on PD 6), cliff avoidance (F5,175 = 2.377, p = 0.041; MAR-ASD > Controls on PDs 
8 and 10), and forelimb strength during vertical screen climbing (F5,175 = 2.811, p = 0.018; 
MAR-ASD > Controls on PD 10). A non-significant trend was additionally observed in 
measuring auditory startle responses on PD 14 (F1,41 = 3.844, p = 0.057), with MAR-ASD 
startling marginally more than control offspring. Finally, interactions of treatment × time × 
sex were found significant for measures of body temperature (F5,175 = 2.405, p = 0.039) and 
negative geotaxis behavior (F5,175 = 2.515, p = 0.032) (Supplemental Tables 7 and 8).
Pup USVs
In assessing the number of USVs emitted by neonatal offspring, a significant treatment × sex 
interaction was detected (F1,50 = 4.662, p = 0.036), with MAR-ASD females emitting 
significantly more USVs than control females (Sidak-adjusted p-value = 0.013) while MAR-
ASD and control males emitted a similar number of USVs on average (Sidak-adjusted p-
value = 0.610) (Figure 3C). Furthermore, a treatment × time interaction approached 
significance (F4,200 = 2.289, p = 0.061), with MAR-ASD offspring emitting significantly 
more USVs on PD 10 relative to controls (Sidak-adjusted p-value = 0.005) (Figure 3D). As 
expected, a significant main effect of day was observed (F4,200 = 17.167, p < 0.001), with 
animals emitting more calls on PDs 6 and 8 relative to PDs 4, 10, and 12. No other 
interactions or main effects were found to approach significance (p > 0.15).
Juvenile reciprocal social interactions
In assessing reciprocal social interactions in same-sex juvenile dyads, a robust behavioral 
profile highly relevant to ASD was observed in MAR-ASD offspring relative to controls. 
Specifically, MAR-ASD mice engaged in significantly fewer bouts of nose-nose sniffing 
(F1,42 = 5.758, p = 0.021), nose-anogenital sniffing (F1,42 = 5.113, p = 0.029), push-crawl 
play behavior (F1,42 = 17.656, p < 0.001), front approach behavior (F1,42 = 24.727, p < 
0.001), and following behavior (F1,42 = 4.372, p = 0.043), indicating lower levels of social 
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behaviors relative to controls. Prenatal exposure to the salient maternal autoantibodies was 
also found to influence repetitive self-grooming behaviors in exposed mice, as MAR-ASD 
juvenile mice engaged in significantly more repetitive self-grooming bouts compared to 
controls (F1,42 = 128.477, p < 0.001). There was no significant effect of treatment on total 
arena exploration (F1,42 = 0.773, p = 0.384). There were no significant effects of offspring 
sex or interactions of treatment × sex for any of the parameters measured (p > 0.10) (Figure 
4; Supplementary Video 1).
Elevated-plus maze
There were no significant differences in the percentage of time spent in the open arms (F1,42 
= 0.071, p = 0.791), number of open arm entries (F1,42 = 1.789, p = 0.188, or in the number 
of total entries (F1,42 = 2.959, p = 0.093) in MAR-ASD offspring relative to controls 
(Supplemental Figures 1A-C).
Light↔Dark exploration
There were no significant differences across treatment groups in the latency to enter the dark 
chamber (F1,42 = 0.129, p = 0.721), time spent in the dark chamber (F1,42 = 0.915, p = 
0.344), or number of transitions between chambers (F1,42 = 0.230, p = 0.634). However, a 
significant main effect of sex was observed for the number of transitions (F1,42 = 6.886, p = 
0.012), with females transitioning between the chambers more frequently than males. No 
other significant main effects or interactions were observed (p > 0.15) (Supplemental 
Figures 2A-D).
Open field
Measures of open field locomotion were normal for MAR-ASD relative to controls in most 
cases. While a significant time × treatment interaction was detected in assessing both 
distance traveled (F5,210 = 2.819, p = 0.017) and horizontal activity (F5,210 = 3.821, p = 
0.002), Sidak-adjusted post-hoc analyses revealed MAR-ASD animals engaged in similar 
exploration as controls except during the first 5 minutes of the task (Distance traveled, p = 
0.057; Horizontal activity, p = 0.040). This seems to be driven in part by a significant time × 
sex interactions (Distance traveled: F5,210 = 6.581, p < 0.001; Horizontal activity: F5,210 = 
9.721, p < 0.001; Vertical Activity: F5,210 = 9.308, p < 0.001), as males consistently 
explored less than females during the first 5 minutes of the 30-minute task (Supplemental 
Figures 3A-F). No other effects of or interactions with treatment were observed as 
significant.
Three-chambered social approach
Typical sociability, defined as spending significantly more time in the chamber containing 
the novel mouse than time in the chamber containing the novel object, was seen in both 
treatments and both sexes (Control males: F1,10 = 27.301, p < 0.001; Control females: F1,10 
= 19.308, p < 0.001; MAR-ASD males: F1,11 = 38.064, p < 0.001; MAR-ASD females: F1,11 
= 8.414, p = 0.014)(Supplemental Figure 4A). Normal sociability was also found for time 
spent sniffing the novel stranger versus time spent sniffing the novel object (Control males: 
F1,10 = 76.179, p < 0.001; Control females: F1,10 = 15.137, p = 0.003; MAR-ASD males: 
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F1,11 = 52.708, p < 0.001), although the observed difference in MAR-ASD females was 
reflected in a non-significant trend (MAR-ASD females: F1,11 = 4.070, p = 0.069)
(Supplemental Figure 4B).
While no differences were observed across treatments or sex for the total number of entries 
to either chamber during the sociability trial (Treatment: F1,42 = 1.098, p = 0.301; Sex: F1,42 
= 2.291, p = 0.138; Treatment × Sex: F1,42 = 0.018, p = 0.894), MAR-ASD mice did not 
enter one chamber more frequently than the other (MAR-ASD males: F1,11 = 3.167, p = 
0.103; MAR-ASD females: F1,11 = 2.200, p = 0.166)(Supplemental Figure 4C). Control 
animals, however, entered the chamber containing the novel mouse significantly more 
frequently than entering the chamber containing the novel object (Control males: F1,10 = 
26.783, p < 0.001; Control females: F1,10 = 7.042, p = 0.024). No significant main effects or 
interactions observed in distance traveled during social approach testing (p > 0.05)
(Supplemental Figure 4D). There were similarly no observed main effects or interactions 
observed in assessing both chamber time and chamber entries during the habituation session 
preceding social approach testing (p > 0.05)(Supplemental Figures 4E-F).
Male-female social interactions and ultrasonic vocalizations
Relative to control males, adult MAR-ASD males displayed deficits on several parameters 
measured during reciprocal social interactions with an unfamiliar stimulus female in estrus. 
Prenatal exposure to the salient maternal autoantibodies produced significant reductions in 
the number of bouts of front approach (t(21) = 2.586, p = 0.017), duration of nose-to-
anogenital sniffing (Duration: t(21) = 2.140, p = 0.044; Bouts: t(21) = 1.829, p = 0.082), 
duration and number of bouts of nose-to-body social sniffing (Duration: t(21) = 2.173, p = 
0.041; Bouts: t(21) = 2.890, p = 0.009), and duration and number of bouts of following 
(Duration: t(21) = 3.969, p < 0.001; Bouts: t(21) = 2.760, p = 0.012) in adult MAR-ASD 
males. MAR-ASD males additionally emitted significantly fewer total USVs over the 5-
minute test session (main effect of treatment: F1,20 = 13.459, p = 0.0015) compared to adult 
control males. A robust treatment effect was additionally observed in assessing repetitive 
self-grooming behaviors, as the duration and number of bouts spent grooming was 
significantly higher in MAR-ASD males relative to controls (Duration: t(21) = −3.113, p = 
0.0053; Bouts: t(21) = −5.905, p < 0.0001). Prenatal maternal autoantibody exposure has no 
significant effect on the duration or number of bouts of either nose-to-nose sniffing 
(Duration: t(21) = 0.104, p = 0.918; Bouts: t(21) = 1.357, p = 0.189) or total arena 
exploration (Duration: t(21) = −1.234, p = 0.231; Bouts: t(21) = −1.618, p = 0.1205) in adult 
male mice relative to controls (Figures 5A-H; Supplemental Table 9; Supplementary Video 
2).
Neurological and physical health screen
Adult male and female offspring were evaluated on measures of general health and 
neurological reflexes. MAR-ASD and control mice scored similarly on measures of fur, 
body tone, limb tone, lack of physical abnormalities, missing whiskers, presence of auditory 
startle, righting reflex, whisker twitch response, ear twitch response, corneal reflex, forepaw 
reaching, wire hanging, and vocalization. A treatment effect was observed in assessing the 
amount of dowel biting (Χ2(2) = 6.409, p = 0.041), with MAR-ASD offspring engaging in 
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less dowel biting behaviors compared to controls. This effect was not evident in assessing 
male offspring (Χ2(2)=3.494, p = 0.174), but was evident when assessing females only 
(Χ2(1)=5.282, p = 0.022). As anticipated, a significant sex effect was observed in measuring 
body weight in adult mice (F1,42 = 87.685, p < 0.001). No other treatment or sex effects 
reached significance.
Repetitive self-grooming behaviors
A total of 3 outliers, defined as being greater than 3 box-lengths from the edge of the box in 
a boxplot, were identified and subsequently excluded from the following analysis of empty 
cage behaviors (1 control male, 1 control female, and 1 MAR-ASD male). Within the 
remaining 43 animals, MAR-ASD offspring were found to engage in repetitive self-
grooming behaviors for a significantly more time than control mice (F1,39 = 7.075, p = 
0.011). There was no effect of sex (F1,39 = 2.790, p = 0.103), or treatment × sex interaction 
(F1,39 = 0.202, p = 0.656), on repetitive self-grooming behaviors in the empty cage 
(Supplemental Figure 5).
Marble burying
The total number of marbles buried, reflective of repetitive digging behaviors, was not 
significantly different between MAR-ASD and control animals (F1,42 = 0.015, p = 0.902) 
(Supplemental Figure 6A). A non-significant trend of offspring sex was observed, with 
males burying moderately more marbles than female mice during the 30-minute task (F1,42 = 
3.619, p = 0.064; treatment × sex interaction: F1,42 = 0.313, p = 0.579) (Supplemental Figure 
6B).
Morris water maze acquisition and reversal
Evaluation of spatial learning on the Morris water maze showed that both MAR-ASD and 
control males and females displayed similar learning curves during acquisition training. 
Mice performed normally, with similar latencies to reach the hidden platform (Treatment: 
F1,42 < 0.001, p = 0.991) and distance traveled to the platform (Treatment: F1,42 = 0.698, p = 
0.408) during hidden platform learning. A significant effect of treatment was observed in 
assessing swim speed during acquisition training (F1,42 = 7.146, p = 0.011), with MAR-ASD 
mice swimming at a moderately slower speed relative to controls. Selective search of the 
trained quadrant of the pool was significant for both MAR-ASD and control mice (p < 
0.001), indicating normal hippocampal-dependent learning using distal cues (Treatment: 
F1,42=0.521, p = 0.475). Time spent in the target quadrant during the probe trial was also 
found to be similar between MAR-ASD and control offspring, with animals spending 
significantly more time in the target quadrant than all other quadrants (p < 0.020). 
Performance during reversal training was additionally similar between MAR-ASD and 
control mice, with comparable latencies to reach the hidden platform (Treatment: F1,42 = 
0.335, p = 0.566), distance traveled to the platform (Treatment: F1,42 = 1.199, p = 0.280), 
and swim speeds (Treatment: F1,42 = 1.135, p = 0.293). In the probe trial conducted 3 hours 
after the last reversal training trial, both MAR-ASD and control animals displayed 
significant selective quadrant search, spending significantly more time in the new training 
quadrant than time in any of the three other quadrants (p < 0.025)(Supplemental Figure 7).
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DISCUSSION
ASD is highly heterogeneous neurodevelopmental disorder whose various etiologies remain 
under investigation. The identification of biological factors that provide indicators of risk as 
well potential pathological mechanisms are critical for achieving the future goal of more 
targeted and individualized therapies51. Therefore, the present study aimed to create the first 
endogenous preclinical model of MAR ASD to directly assess the pathological significance 
of ASD-specific maternal autoantibodies through the generation of disorder-relevant 
behaviors and altered developmental milestones in prenatally exposed offspring. Where 
previous studies employed a passive antibody approach, the current study administered 
specific peptide antigens to females prior to breeding to ensure a continuous exposure to the 
endogenously generated antibodies from conception through birth. Prenatally exposed 
MAR-ASD male and female offspring displayed a range of ASD-relevant behaviors 
throughout life, including aberrant social interactions between juvenile dyads and in adult 
males interacting with estrous females, higher repetitive self-grooming behaviors, reduced 
vocalizations emitted during social interactions, and significant alterations in developmental 
milestones including increased head size. Thus, we have successfully demonstrated for the 
first time that these ASD-specific maternal autoantibodies are directly related to behavioral 
changes in prenatally exposed offspring.
The assays employed in the current study expand upon those used in our prior passive IgG 
transfer studies20, 23, 25, 26. A comprehensive set of longitudinal mouse behavioral testing 
methods evaluated behaviors relevant to the core diagnostic and associated symptoms of 
ASD in both male and female offspring. In the social behavioral domain, significant 
decreases in reciprocal social interactions during dyadic play were observed in MAR-ASD 
male and female offspring relative to controls, both as juveniles (JRSI) and as adults (MFSI). 
However, normal social approach scores were observed in both control and MAR-ASD 
offspring during the three-chamber assay. The disparity between these findings is likely due 
to the binary yes-or-no outcome nature of the three-chambered social approach task, 
whereas dyadic play is a more sensitive fine-grained behavioral analysis tool46. Furthermore, 
MAR-ASD male offspring emitted significantly fewer vocalizations in response to social 
cues as adults (MFSI USVs) relative to controls, while MAR-ASD females emitted 
significantly more vocalizations in response to social isolation as pups (pup USVs). Of the 
behavioral findings observed from several human and animal studies of MAR ASD, the 
most robust and consistent finding is the marked presence of repetitive and stereotypical 
behaviors in MAR-ASD exposed offspring28. We found robust increases in repetitive self-
grooming behaviors in male and female MAR-ASD offspring during dyadic play (JRSI and 
MFSI) and when placed in an empty cage. We did not observe any differences between 
treatment groups in the marble burying task; however, this finding contributes to the existing 
question in the behavior neuroscience field about whether marble burying in fact represents 
a repetitive behavior44, 52.
While there were an extensive number of ASD-related behavioral findings, there were also 
several assays for which MAR-ASD male and female offspring behaved similarly to 
controls. For example, measures of general health and neurological reflexes were 
comparable between MAR-ASD and control adult mice. No anxiety-like phenotype was 
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detected in MAR-ASD male and female offspring, as determined via the elevated plus-maze 
and light↔dark exploration assays. Normal general exploratory locomotion in an open field 
were observed in MAR-ASD and control mice. The lack of any noticeable treatment effects 
on anxiety- or locomotor- relevant behaviors suggests that tasks in which treatment 
differences are observed are unlikely to be influenced by competing behavioral confounds, 
such as sedation or hyperactivity44. These findings correlate with what is noted clinically 
with MAR ASD. In addition, no cognitive deficits were detected in MAR-ASD offspring 
relative to controls during the Morris water maze task, which is supported by neurotypical 
cognitive abilities observed clinically in children with the MAR subtype of ASD16, 28.
In assessing markers of early physical development and neurological reflexes in neonatal 
offspring, we observed several differences between MAR-ASD and control offspring 
indicative of an altered neurodevelopmental trajectory. Of these, the most striking was the 
increased head size of MAR-ASD male and female pups. This finding, which persisted after 
correcting for body size and weight, mirrors that of the clinical population. In particular, 
children with the MAR subtype of ASD have significantly increased cerebral volumes in 
comparison to not only TD control children, but children with non-MAR ASD27. Of 
additional interest, MAR-ASD litters produced significantly more females than control 
litters. While intriguing, further study is necessary to replicate and interpret this finding.
Other laboratories have described the presence of maternal autoantibodies associated with a 
diagnosis of ASD. For example, using a technical approach different than in our previous 
studies7, Brimberg et al. examined maternal samples from the Simons Simplex Collection 
for reactivity against mouse tissue sections using immunofluorescence. They found that 
mothers of children with ASD were four times as likely to have circulating anti-brain 
antibodies, but the antibodies were not entirely specific to ASD53. This study led to the 
identification of contactin-associated protein-like 2 (CASPR2)-reactive maternal 
autoantibodies, and the subsequent mouse model of Caspr2-reactive antibody for risk for 
ASD with some behaviors reminiscent of ASD24. This work highlights the importance 
multiple investigators taking on this critical area of research while employing a variety of 
approaches.
While the etiology of maternal autoantibody generation in the mothers is unclear, studies 
that aim to gain an understanding of the pathogenic mechanisms are currently underway. 
One risk factor identified to be strongly associated with the presence of these ASD-specific 
maternal autoantibodies is a functional variant in the 5’ promoter region of the MET 
receptor tyrosine kinase gene54. This variant, rs1858830 or the ‘MET C allele,’ is a common 
G-to-C single-nucleotide polymorphism (SNP) that has independently been associated with 
increased risk of ASD55–59. Furthermore, the MET C allele was associated with decreased 
MET protein expression and decreased levels of interleukin-10 (IL-10) in activated 
peripheral blood mononuclear cells from these mothers54. A second identified risk factor of 
MAR ASD is metabolic conditions experienced during pregnancy60. In particular, maternal 
autoantibody prevalence was observed to be more prevalent amongst mothers diagnosed 
with hypertensive disorders, mothers diagnosed with diabetes (type 2 or gestational), and 
among those mothers who were moderately overweight (body mass index of 27.0 – 29.9) 
compared to healthy mothers60. Finally, in a distinct but similar study, Brimberg et al. found 
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that autoantibody-positive mothers of children with ASD were more likely to have an 
autoimmune disease such as rheumatoid arthritis and systemic lupus erythematous9. Thus, 
while the etiology of the maternal autoantibodies in humans remains unknown, through the 
generation of the current mouse model coupled with ongoing molecular and 
neuroanatomical studies in these animals, we will begin to understand the pathogenic 
mechanisms associated with MAR ASD.
Although our endogenous model supports a direct pathological association with one type of 
ASD, this is not reflective of all MAR risk for ASD, as we examined only one antigenic 
MAR ASD autoantibody pattern. Efforts to recapitulate our findings in a cross-species 
model are currently underway, as well as ongoing studies to create models for other 
significant autoantibody patterns of MAR ASD. Additionally, studies to examine whether 
the behavioral phenotype of the offspring is paralleled by ASD-relevant changes in terms of 
neuroanatomy and neuromorphology, as well as gene and protein expression within the 
developing and adult brain, are currently in progress. The establishment of endogenous, 
antigen-driven preclinical models is a critical step towards the advancement of this work to 
the clinical setting. To best ensure the translational success of these preclinical models, 
research is ongoing to further identify the behavioral phenotypes associated with each 
maternal autoantibody reactivity pattern using well-characterized clinical cohorts. 
Translational animal models provide the underpinnings for understanding the underlying 
mechanisms related to maternal autoantibodies in ASD, as well as the development of future 
therapeutic interventions for a subset of individuals with ASD.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. A depiction of the breeding strategies and behavioral testing timeline used in the 
present study.
A) Two cohorts of experimental dams were bred to produce the male and female 
experimental offspring tested in a comprehensive behavioral testing array. B) Behavioral 
testing timeline of the three separate groups of experimental MAR-ASD and control male 
and female offspring.
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Figure 2. Production of endogenous maternal autoantibodies towards the targeted peptide 
epitope sequences.
Average maternal autoantibody reactivity towards epitope-specific peptide sequences at (A-
D) pre-gestational and (E-H) post-parturition time points is illustrated. Average maternal 
reactivity towards peptides of LDH-A (A, E), LDH-B (B, F), STIP1 (C, G), and CRMP1 (D, 
H) are displayed (Mean ± SEM). *average peptide reactivity p<0.05, **p<0.01, ***p<0.001.
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Figure 3: Developmental milestones and isolation-induced ultrasonic vocalization in pups.
Several measures of rodent developmental milestones were significantly different between 
MAR-ASD and control pups, such as increased body weight (A) and head width (B) in 
MAR-ASD male and female pups (controlled for total body weight). In measuring USVs 
emitted by pups in response to social isolation, MAR-ASD female pups emitted significantly 
more USVs than control females (C) and a non-significant treatment × time interaction trend 
revealed MAR-ASD male and female offspring emit significantly more USVs on PD 10 
compared to control male and female pups (D). *p<0.05
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Figure 4. Juvenile reciprocal social interactions.
Male and female MAR-ASD offspring exhibited significantly less bouts of nose-nose sniff 
(A), nose-anogenital sniff (B), push-crawl (C), front approach (D), and following (E) during 
10 minutes of dyadic play with an age- and sex- matched novel C57BL/6J stimulus partner 
mouse. MAR-ASD mice exhibited significantly higher levels of repetitive self-grooming 
behaviors (F) relative to controls but were similar to controls on exploration of the arena (G). 
*p<0.05
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Figure 5. Male-female social interactions.
MAR-ASD adult males exhibited ASD-relevant behaviors during 5-min dyadic play with a 
novel female in estrus. While no significant difference was observed in nose-nose sniff (A), 
MAR-ASD adult males spent significantly less time engaging in nose-anogenital sniff (B), 
body sniff (C), front approach (D), and following social behaviors (E). MAR-ASD males 
also exhibited significantly higher levels of repetitive self-grooming behaviors (F) but were 
similar to controls in exploration of arena (G). Compared to control males, MAR-ASD adult 
males additionally emitted significantly fewer total USVs over the 5-min test session (H). 
*p<0.05
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